BEUDAMED
    FDA Adverse Event Injury Summary report: N

    MOTIVA IMPLANTS

    MDR report key: 24932299 · Received April 20, 2026

    Report

    Report Number
    3012883202-2026-02193
    Event Type
    Injury
    Date Received
    April 20, 2026
    Date of Event
    December 17, 2025
    Report Date
    May 5, 2026
    Manufacturer
    ESTABLISHMENT LABS S.A.
    Product Code
    FTR
    UDI-DI
    07445161010711
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    US
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    THE ALLEGED EVENT IS A RISK ASSOCIATED WITH BREAST SURGERY AND THERE IS NO EVIDENCE TO SUGGEST A LINK BETWEEN THIS PARTICULAR IMPLANT AND/OR ITS MANUFACTURING PROCESS AND A HIGHER RISK OF OCCURRENCE. THE CAUSE OF CAPSULAR CONTRACTURE IS MULTIFACTORIAL, AND WE CANNOT CONCLUDE THAT THE REPORTED EVENT WAS CAUSED BY THE MANUFACTURING PROCESS AND/OR THE PRODUCT ITSELF. A COMPLETE REVIEW OF THE DHR FOR LOT INVOLVED WAS CARRIED OUT, NO DEVIATION WAS FOUND IN THE MANUFACTURING PROCESS. ADDITIONALLY, THERE WERE NO INDICATIONS OF ABNORMALITIES IN RAW MATERIALS OR MANUFACTURING PROCESSES WHICH MAY HAVE AFFECTED THIS PARTICULAR BATCH. THE INSTRUCTIONS FOR USE IN THE DIRECTIONS FOR USE WERE REVIEWED, TO DETERMINATE IF THERE ARE INDICATIONS THAT ENSURE THE PREVENTION AND GOOD HANDLING OF THE PRODUCT. FOR THIS EVENT, IT IS CONSIDERED THAT THE INFORMATION IS SUITABLE FOR THE SECTION OF SURGICAL PRECAUTIONS AS FOLLOWS: CAPSULAR CONTRACTURE: "A CAPSULAR CONTRACTURE PERTAINS TO HYPERTROPHIC SCAR TISSUE INVESTING IN A FOREIGN BODY OR SURGICALLY IMPLANTED DEVICE, COMPROMISING THE AESTHETIC OUTCOME, RESULTING IN PAIN, BREAST DEFORMITY, AND OFTEN NECESSITATING FURTHER OPERATIONS4 . DETECTION OF BREAST CANCER BY MAMMOGRAPHY MAY ALSO BE CHALLENGING. CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWING INFECTION, HEMATOMA AND SEROMA, AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME. CAPSULAR CONTRACTURE OCCURS MORE COMMONLY IN PATIENTS UNDERGOING REVISION SURGERY THAN IN PATIENTS UNDERGOING PRIMARY IMPLANTATION SURGERY. CAPSULAR CONTRACTURE IS THE MOST COMMON COMPLICATION FOLLOWING IMPLANT- BASED BREAST SURGERY AND IS ONE OF THE MOST COMMON REASONS FOR REOPERATION". PER OUR DIRECTIONS FOR USE, EACH PATIENT MUST RECEIVE THE ESTABLISHMENT LABS S.A. ¿MOTIVA IMPLANTS®: INFORMATION FOR THE PATIENT¿ DURING HER SURGICAL CONSULTATION, IT IS THE SURGEONS´ RESPONSIBILITY TO ENSURE THAT THE PATIENT COMPLETELY UNDERSTANDS THE INFORMATION REGARDING THE RISKS, BENEFITS, AND RECOMMENDATIONS ASSOCIATED WITH SILICONE GEL-FILLED BREAST IMPLANT SURGERY, AS WELL AS THE COMPLICATIONS TYPICAL OF ANY TYPE OF SURGERY. THIS DOCUMENT IS AVAILABLE IN MOTIVA® WEBSITE: IFU.MOTIVA. HEALTH. AS STATED IN THE LITERATURE: THE MOST COMMON OVERALL INDICATION FOR REOPERATION IS CAPSULAR CONTRACTURE (HANDEL, 2006). CAPSULAR CONTRACTURE PRODUCES ASYMMETRY BETWEEN BOTH BREASTS EITHER IN BILATERAL (WHEN THE DEGREE OF AFFECTATION IS DIFFERENT) OR UNILATERAL CASES. THE PATIENT MAY PRESENT DISCOMFORT IN THE CONTRACTING BREASTS, SUCH AS COLDNESS AND PAIN (F. J. ESCUDERO ET AL., 2005). CAPSULAR CONTRACTURE OCCURS APPROXIMATELY FIVE TIMES MORE FREQUENTLY WITH SMOOTH SURFACE IMPLANTS COMPARED WITH TEXTURED SURFACE IMPLANTS (BARNSLEY, ET AL. 2006). ESTABLISHMENT LABS WILL CONTINUE TO MONITOR FOR SIMILAR COMPLAINTS/TRENDS. AS PART OF THE POST MARKET SURVEILLANCE PROCESS, MONITORING OF THE PRIMARY ENDPOINTS REPORTED IS PERFORMED TO DETERMINE UNFAVORABLE TRENDS. PER OUR CURRENT COMPLAINT DATA REPORT, NO UNFAVORABLE TRENDS WERE DETECTED ON THIS PRODUCT. NO FURTHER ACTIONS ARE REQUIRED.

    Description of Event or Problem · 0

    KOREA. ALLEGEDLY, A PATIENT IS EXPERIENCING CHANGES IN THE BREAST, AS SHE REPORTED A CHANGE IN BREAST SHAPE AND INCREASED FIRMNESS, DESCRIBING THE BREAST AS HARD. THESE REPORTED SIGNS AND SYMPTOMS ARE CONSISTENT WITH A BILATERAL CAPSULAR CONTRACTURE BAKER GRADE III. (SN: (B)(6). A REVISION SURGERY WAS PERFORMED. NO PATIENT DEMOGRAPHICS, SUCH AS WEIGHT, OR ETHNICITY, WERE PROVIDED BY THE REPORTER. EFFORTS TO GATHER ADDITIONAL INFORMATION ARE ONGOING, AND THE INVESTIGATION REMAINS IN PROGRESS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    313243 MOTIVA IMPLANTS ERGONOMIX ROUND SILKSURFACE FTR ESTABLISHMENT LABS S.A. 21090347 07445161010711

    Patients

    Seq Age Sex Outcome Treatment
    1